[
  {
    "ts": null,
    "headline": "HIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin Down",
    "summary": "Hims & Hers' first-quarter 2025 performance reflects continued strength in its online revenue channel on the back of solid product demand and an increasing subscriber base.",
    "url": "https://finnhub.io/api/news?id=b33e04348a19b18c53110be4790a79b959deff54cca919112a58289f37ecccd2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746550800,
      "headline": "HIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin Down",
      "id": 134290263,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Hims & Hers' first-quarter 2025 performance reflects continued strength in its online revenue channel on the back of solid product demand and an increasing subscriber base.",
      "url": "https://finnhub.io/api/news?id=b33e04348a19b18c53110be4790a79b959deff54cca919112a58289f37ecccd2"
    }
  },
  {
    "ts": null,
    "headline": "INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts",
    "summary": "Inspire Medical's first-quarter 2025 performance reflects increased market penetration in existing centers and expansion into new territories and centers, along with strong domestic results.",
    "url": "https://finnhub.io/api/news?id=2be65b216473fd9c44cfcec5a19a3558a411b05ddc611bef88c07448d25ec0a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746548940,
      "headline": "INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts",
      "id": 134290264,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Inspire Medical's first-quarter 2025 performance reflects increased market penetration in existing centers and expansion into new territories and centers, along with strong domestic results.",
      "url": "https://finnhub.io/api/news?id=2be65b216473fd9c44cfcec5a19a3558a411b05ddc611bef88c07448d25ec0a1"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific",
    "summary": "GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific are part of the Zacks top Analyst Blog.",
    "url": "https://finnhub.io/api/news?id=411cc7cdf1e8a3a14b5b8e2c90c29fb78104f225f98456900647d321d893193b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746537000,
      "headline": "The Zacks Analyst Blog Highlights GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific",
      "id": 134266271,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "GE Healthcare, Johnson & Johnson, Abbott and Boston Scientific are part of the Zacks top Analyst Blog.",
      "url": "https://finnhub.io/api/news?id=411cc7cdf1e8a3a14b5b8e2c90c29fb78104f225f98456900647d321d893193b"
    }
  },
  {
    "ts": null,
    "headline": "These 4 Measures Indicate That Boston Scientific (NYSE:BSX) Is Using Debt Safely",
    "summary": "Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...",
    "url": "https://finnhub.io/api/news?id=daf0824cbababb290a8ddf35732c5f47675cb435f19d20fd42573ad3c9ba5811",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746529239,
      "headline": "These 4 Measures Indicate That Boston Scientific (NYSE:BSX) Is Using Debt Safely",
      "id": 134266488,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...",
      "url": "https://finnhub.io/api/news?id=daf0824cbababb290a8ddf35732c5f47675cb435f19d20fd42573ad3c9ba5811"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Blue Chip Growth ETF Q1 2025 Commentary",
    "summary": "For the quarter, the Fidelity Blue Chip Growth ETF NAV returned -13.33% and its market price returned -13.60%, lagging its benchmark. Click here to read more.",
    "url": "https://finnhub.io/api/news?id=788b9dfe467245dba8d822e538e00a9f259d5f9129f7c16d9bb140668bc1b348",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746509100,
      "headline": "Fidelity Blue Chip Growth ETF Q1 2025 Commentary",
      "id": 134259718,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/822015000/image_822015000.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "For the quarter, the Fidelity Blue Chip Growth ETF NAV returned -13.33% and its market price returned -13.60%, lagging its benchmark. Click here to read more.",
      "url": "https://finnhub.io/api/news?id=788b9dfe467245dba8d822e538e00a9f259d5f9129f7c16d9bb140668bc1b348"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Balanced Fund Q1 2025 Review",
    "summary": "For the first quarter of 2025, the fund's Retail Class shares returned -2.74%, trailing the -1.45% result of the Fidelity Balanced Hybrid Composite Index SM.",
    "url": "https://finnhub.io/api/news?id=96f3f5c60ede529da6ebb0a114c97f3d6c4a941a342ac4161f32b74d00aba658",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746503100,
      "headline": "Fidelity Balanced Fund Q1 2025 Review",
      "id": 134259196,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1310052459/image_1310052459.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "For the first quarter of 2025, the fund's Retail Class shares returned -2.74%, trailing the -1.45% result of the Fidelity Balanced Hybrid Composite Index SM.",
      "url": "https://finnhub.io/api/news?id=96f3f5c60ede529da6ebb0a114c97f3d6c4a941a342ac4161f32b74d00aba658"
    }
  },
  {
    "ts": null,
    "headline": "Reflecting On Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Stryker (NYSE:SYK)",
    "summary": "Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Stryker (NYSE:SYK) and its peers.",
    "url": "https://finnhub.io/api/news?id=1768cb98be5705e568d49b3668a3e535789ed7de700b76f9b22a98d54f3347fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746502315,
      "headline": "Reflecting On Medical Devices & Supplies - Diversified Stocks’ Q1 Earnings: Stryker (NYSE:SYK)",
      "id": 134266376,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Stryker (NYSE:SYK) and its peers.",
      "url": "https://finnhub.io/api/news?id=1768cb98be5705e568d49b3668a3e535789ed7de700b76f9b22a98d54f3347fe"
    }
  }
]